These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3587916)

  • 21. Proton irradiation for peripapillary and parapapillary melanomas.
    Lane AM; Kim IK; Gragoudas ES
    Arch Ophthalmol; 2011 Sep; 129(9):1127-30. PubMed ID: 21911661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
    Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
    Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study.
    Linstadt D; Char DH; Castro JR; Phillips TL; Quivey JM; Reimers M; Hannigan J; Collier JM
    Int J Radiat Oncol Biol Phys; 1988 Aug; 15(2):347-52. PubMed ID: 3403315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive factors of visual outcome after local resection of choroidal melanoma.
    Damato BE; Paul J; Foulds WS
    Br J Ophthalmol; 1993 Oct; 77(10):616-23. PubMed ID: 8218028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ocular complications after iodine brachytherapy for large uveal melanomas.
    Puusaari I; Heikkonen J; Kivelä T
    Ophthalmology; 2004 Sep; 111(9):1768-77. PubMed ID: 15350335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.
    Aziz HA; Singh N; Bena J; Wilkinson A; Singh AD
    JAMA Ophthalmol; 2016 Jun; 134(6):615-20. PubMed ID: 27101414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The risk of enucleation after proton beam irradiation of uveal melanoma.
    Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
    Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visual acuity related to retinal distance from the fovea in macular disease.
    Weiter JJ; Wing GL; Trempe CL; Mainster MA
    Ann Ophthalmol; 1984 Feb; 16(2):174-6. PubMed ID: 6703589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plaque radiotherapy for uveal melanoma: long-term visual outcome in 1106 consecutive patients.
    Shields CL; Shields JA; Cater J; Gündüz K; Miyamoto C; Micaily B; Brady LW
    Arch Ophthalmol; 2000 Sep; 118(9):1219-28. PubMed ID: 10980767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year follow-up of helium ion therapy for uveal melanoma.
    Char DH; Castro JR; Kroll SM; Irvine AR; Quivey JM; Stone RD
    Arch Ophthalmol; 1990 Feb; 108(2):209-14. PubMed ID: 2302103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of dose to the macula, optic disc, and lens in relation to vision toxicities - A retrospective study using COMS eye plaques.
    Oare C; Sun S; Dusenbery K; Reynolds M; Koozekanani D; Gerbi B; Ferreira C
    Phys Med; 2022 Sep; 101():71-78. PubMed ID: 35981450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macular uveal melanoma treated with proton beam irradiation. 10-year follow-up observation with histopathologic correlation.
    Young LH; Gragoudas ES
    Retina; 1994; 14(1):43-6. PubMed ID: 8016461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes after Proton Beam Irradiation in Patients with Choroidal Melanoma Eligible for Investigational AU-011 Treatment.
    Wu F; Lane AM; Trofimov A; Shih HA; Gragoudas ES; Kim IK
    Ocul Oncol Pathol; 2023 Dec; 9(5-6):152-157. PubMed ID: 38089176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Risk Factors for Radiation Vasculopathy.
    Papakostas TD; Morrison MA; Lane AM; Awh C; DeAngelis MM; Gragoudas ES; Kim IK
    Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1547-1553. PubMed ID: 29625478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ciliochoroidal melanomas treated with a narrow medical proton beam.
    Brovkina AF; Zarubei GD
    Arch Ophthalmol; 1986 Mar; 104(3):402-4. PubMed ID: 3006648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preliminary results of proton beam irradiation of macular and paramacular melanomas.
    Gragoudas ES; Goitein M; Seddon J; Verhey L; Munzenrider J; Urie M; Suit HD; Blitzer P; Johnson KN; Koehler A
    Br J Ophthalmol; 1984 Jul; 68(7):479-85. PubMed ID: 6329261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of treatment with stereotactic radiosurgery or proton beam therapy for choroidal melanoma.
    Sikuade MJ; Salvi S; Rundle PA; Errington DG; Kacperek A; Rennie IG
    Eye (Lond); 2015 Sep; 29(9):1194-8. PubMed ID: 26160531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for neovascular glaucoma after proton beam therapy of uveal melanoma: a detailed analysis of tumor and dose-volume parameters.
    Mishra KK; Daftari IK; Weinberg V; Cole T; Quivey JM; Castro JR; Phillips TL; Char DH
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):330-6. PubMed ID: 23886415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma.
    Gragoudas ES; Lane AM; Regan S; Li W; Judge HE; Munzenrider JE; Seddon JM; Egan KM
    Arch Ophthalmol; 2000 Jun; 118(6):773-8. PubMed ID: 10865313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.